Innovation meets quality: moving cellular therapies at the National Institutes for Health from bench to bedside
Read, E.J.
CytoTherapy 6(6): 626-628
2004
ISSN/ISBN: 1465-3249
PMID: 15764029
DOI: 10.1080/14653240410005302
Accession: 049364304
The National Institutes of Health (NIH) Department of Transfusion Medicine has supported clinical investigation in cellular therapies over the past 20 years. This experience, which encompasses product development research, quality system design and product manufacturing for a wide range of early phase clinical trials, provides a firm basis for future work with novel stem cell therapies.
PDF emailed within 0-6 h: $19.90
Related References
Jahangiri, A.; Flanigan, P.M.; Arnush, M.; Chandra, A.; Rick, J.W.; Choi, S.; Chou, A.; Berger, M.S.; Aghi, M.K. 2019: From bench to bedside: trends in National Institutes of Health funding for neurosurgeons from 1991 to 2015 Journal of Neurosurgery 2019: 1-10Lauer, M.S.; Skarlatos, S. 2010: Translational research for cardiovascular diseases at the National Heart, Lung, and Blood Institute: moving from bench to bedside and from bedside to community Circulation 121(7): 929-933
Riley, J.; Hurtig, C.V.; Boulis, N. 2012: Translating cellular therapies from bench to bedside for amyotrophic lateral sclerosis Personalized Medicine 9(6): 645-655
Fridsma, D. 2016: Health Informaticians Drive Innovation from Bench to Bedside Biomedical Instrumentation and Technology 50(5): 371-375
Cashion, A.K.; Grady, P.A. 2015: The National Institutes of Health/National Institutes of Nursing Research intramural research program and the development of the National Institutes of Health Symptom Science Model Nursing Outlook 63(4): 484-487
Cohen, J. 1993: National Institutes of Health. Strategic plan meets the bureaucracy Science 261(5117): 23
Tang, Y.; Wang, S.; Wang, Y.; Xing, X.; Yu, Y.; Dong, W. 2014: Bridging the gap from bench to bedside: China takes a new look at moving innovative health care ideas into the marketplace IEEE Pulse 5(1): 55-58
Kaur, N.; Raja, R.; Ruiz-Velasco, A.; Liu, W. 2020: Cellular Protein Quality Control in Diabetic Cardiomyopathy: from Bench to Bedside Frontiers in Cardiovascular Medicine 7: 585309
Maruo, T. 2010: Translational research in women's health: from bedside to bench and from bench to bedside International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 109(2): 83-84
Shabason, J.E.; Tofilon, P.J.; Camphausen, K. 2011: Grand rounds at the National Institutes of Health: HDAC inhibitors as radiation modifiers, from bench to clinic Journal of Cellular and Molecular Medicine 15(12): 2735-2744
Portnoy, B.; Miller, J.; Brown-Huamani, K.; DeVoto, E. 2007: Impact of the National Institutes of Health Consensus Development Program on stimulating National Institutes of Health-funded research, 1998 to 2001 International Journal of Technology Assessment in Health Care 23(3): 343-348
Edelman, R. 1984: From The National Institutes of Health. Summary of the National Institutes of Health Research Workshop on the Epidemiology of the Acquired Immunodeficiency Syndrome (AIDS) Journal of Infectious Diseases 150(2): 295-303
Berger; Ogawa; McMinn; Wu; Schultz; Romesberg 2000: Stable and Selective Hybridization of Oligonucleotides with Unnatural Hydrophobic Bases This work was supported by the National Institutes of Health (GM 60005 to F.E.R.) and the Skaggs Institute for Chemical Biology (F.E.R. and P.G.S.). A.K.O. thanks the National Institutes of Health for a postdoctoral fellowship (F32 GM19833-01) Angewandte Chemie 39(16): 2940-2942
Nair, R.P.; Ding, J.; Duffin, K.C.; Helms, C.; Voorhees, J.J.; Krueger, G.G.; Bowcock, A.M.; Abeçasis, G.R.; Elder, J.T. 2009: Psoriasis bench to bedside: genetics meets immunology Archives of Dermatology 145(4): 462-464
Tschider, C.A. 2014: Innovation in the public sphere: reimagining law and economics to solve the National Institutes of Health publishing controversy Journal of Law and the Biosciences 1(3): 281-315
Frontera, W.R.; Bean, J.F.; Damiano, D.; Ehrlich-Jones, L.; Fried-Oken, M.; Jette, A.; Jung, R.; Lieber, R.L.; Malec, J.F.; Mueller, M.J.; Ottenbacher, K.J.; Tansey, K.E.; Thompson, A. 2017: Rehabilitation Research at the National Institutes of Health: Moving the Field Forward (Executive Summary) American Journal of Physical Medicine and Rehabilitation 96(4): 211-220
Engstrom, L.O. 1985: The national institutes of health small business innovation research program opportunities for orphan drug development Van Woert, M H And E Chung (Ed ) Progress in Clinical And Biological Research, Vol 197 Cooperative Approaches to Research And Development Of Orphan Drugs; Meeting, New York, N Y , Usa, Apr 9-10, 1984 Xi+204p Alan R Liss, Inc : New York, N Y , Usa Illus Maps 25-30
Stroncek, D.; Harvath, L.; Barrett, J. 2002: National Heart, Lung, and Blood Institute of the National Institutes of Health forum on immune reconstitution and cellular therapy following hematopoietic stem-cell transplantation CytoTherapy 4(5): 415-418
Feldmann, R.J. 1984: Molecular and cellular graphics at the national institutes of health Biophysical Journal 45(2 Part 2): 132A
Engstrom, L.O. 1985: The National Institutes of Health Small Business Innovation Research (SBIR) Program: opportunities for orphan drug development Progress in Clinical and Biological Research 197: 25-30